Javascript must be enabled to continue!
Proarrhythmic Effect of Pacemaker Stimulation in Patients With Implanted Cardioverter-Defibrillators
View through CrossRef
Background—
We sought to determine the potential of right ventricular VVI backup pacing to induce ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
Methods and Results—
All consecutive patients presenting exclusively with pacemaker-induced tachycardias (PITs) were included in a prospective study using a crossover protocol. Patients were randomized to either group 1 (augmentation of the baseline frequency of the pacemaker to 60 bpm) or group 2 (pacemaker turned off) and were followed up for 1 year and then crossed over to the other programming, looking for reoccurrence of PIT. Of 150 consecutive patients, 39 (26%) had PIT, 13 of them exclusively (8.6%). Forty of 1063 analyzed tachyarrhythmias of all the patients were PIT (3%). Before inclusion in the study, the patients had 2.7±0.9 PITs in 11±6.5 months with their pacemakers programmed empirically at 42.3 bpm. During the study phase, no PIT occurred while the pacemaker was turned off, whereas programming to 60 bpm led to the recurrence of PIT in 5 of 6 patients (1.4±0.6 per patient). At the end of the study, 9 patients underwent a prolonged follow-up with their pacemakers turned off, resulting in spontaneous episodes of ventricular tachycardia/fibrillation in 5 patients, but PITs were no longer observed.
Conclusions—
This crossover protocol proves the potential proarrhythmic effect of pacemaker stimulation in implantable cardioverter-defibrillator patients. Resulting PITs led to clinical symptoms and antitachycardia therapy by the implantable cardioverter-defibrillator. Thus, in patients presenting with PIT but without a pacemaker indication, the pacemaker feature should be turned off, or, alternatively, the longest possible escape interval should be programmed.
Ovid Technologies (Wolters Kluwer Health)
Title: Proarrhythmic Effect of Pacemaker Stimulation in Patients With Implanted Cardioverter-Defibrillators
Description:
Background—
We sought to determine the potential of right ventricular VVI backup pacing to induce ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
Methods and Results—
All consecutive patients presenting exclusively with pacemaker-induced tachycardias (PITs) were included in a prospective study using a crossover protocol.
Patients were randomized to either group 1 (augmentation of the baseline frequency of the pacemaker to 60 bpm) or group 2 (pacemaker turned off) and were followed up for 1 year and then crossed over to the other programming, looking for reoccurrence of PIT.
Of 150 consecutive patients, 39 (26%) had PIT, 13 of them exclusively (8.
6%).
Forty of 1063 analyzed tachyarrhythmias of all the patients were PIT (3%).
Before inclusion in the study, the patients had 2.
7±0.
9 PITs in 11±6.
5 months with their pacemakers programmed empirically at 42.
3 bpm.
During the study phase, no PIT occurred while the pacemaker was turned off, whereas programming to 60 bpm led to the recurrence of PIT in 5 of 6 patients (1.
4±0.
6 per patient).
At the end of the study, 9 patients underwent a prolonged follow-up with their pacemakers turned off, resulting in spontaneous episodes of ventricular tachycardia/fibrillation in 5 patients, but PITs were no longer observed.
Conclusions—
This crossover protocol proves the potential proarrhythmic effect of pacemaker stimulation in implantable cardioverter-defibrillator patients.
Resulting PITs led to clinical symptoms and antitachycardia therapy by the implantable cardioverter-defibrillator.
Thus, in patients presenting with PIT but without a pacemaker indication, the pacemaker feature should be turned off, or, alternatively, the longest possible escape interval should be programmed.
Related Results
Antiarrhythmic and Proarrhythmic Potential of Pharmacological Agents
Antiarrhythmic and Proarrhythmic Potential of Pharmacological Agents
Antiarrhythmic therapy in general has a problem ‘especially in the treatment
of ventricular arrhythmias’ that the compounds have proarrhythmic potential
which is due to t...
The effects of age on quality of life in implantable cardioverter defibrillator recipients
The effects of age on quality of life in implantable cardioverter defibrillator recipients
Background. The implantable cardioverter defibrillator shows superiority over conventional pharmacological therapy. The implantable cardioverter defibrillator has been implanted w...
Patients’ Perspective on Termination of Pacemaker Therapy—A Cross-Sectional Anonymous Survey among Patients Carrying a Pacemaker in Germany
Patients’ Perspective on Termination of Pacemaker Therapy—A Cross-Sectional Anonymous Survey among Patients Carrying a Pacemaker in Germany
Objective: To determine the opinions of patients regarding the withdrawal of pacemaker therapy. Participants and methods: A cross-sectional anonymous questionnaire was administered...
Long-term implications of pacemaker insertion in younger adults: a single centre experience
Long-term implications of pacemaker insertion in younger adults: a single centre experience
Abstract
Background
The long-term implications of pacemaker insertion in younger adults are poorly described in the literature.
...
Leadless Pacemaker tine fracture and dislocation: two case reports
Leadless Pacemaker tine fracture and dislocation: two case reports
Abstract
The rate of leadless pacemaker implantation is increasing worldwide. To date, there have been few reports of leadless pacemaker dislocation and extraction. This ar...
Long-term analgesic effect of trans-spinal direct current stimulation compared to non-invasive motor cortex stimulation in complex regional pain syndrome
Long-term analgesic effect of trans-spinal direct current stimulation compared to non-invasive motor cortex stimulation in complex regional pain syndrome
Abstract
The aim of the present study was to compare the analgesic effect of motor cortex stimulation using high-frequency repetitive transcranial magnetic stimulati...
P425Single procedure pace and ablate. evaluation of efficacy and safety comparing three different vascular routes
P425Single procedure pace and ablate. evaluation of efficacy and safety comparing three different vascular routes
Abstract
Funding Acknowledgements
No financial support for this study
Introduc...
A New Fight-or-Flight Pacemaker Mechanism via Ryanodine Receptor Abundance and Superclustering
A New Fight-or-Flight Pacemaker Mechanism via Ryanodine Receptor Abundance and Superclustering
Abstract
The sinoatrial node is the primary cardiac pacemaker. Individual sinoatrial node cells (SANCs) generate spontaneous rhythmic action pote...

